Sangamo Therapeutics Inc
SGMO
Loading quote...
Financials
| 52Week High | 3.18 | 52Week Low | 0.41 |
| Beta | 1.19 | Current Ratio Annual | 1.13 |
| Current Ratio Quarterly | 1.05 | Market Cap | 175.73M |
| Net Profit Margin TTM | -77.48 | Operating Margin TTM | -76.91 |
| Price To Book | 8.96 | Price To Free Cash Flow TTM | 15.09 |
| Price To Sales TTM | 2.15 | Quick Ratio Annual | 1.02 |
| Quick Ratio Quarterly | 0.91 | Return On Assets TTM | -63.85 |
| Return On Equity TTM | -293.05 | Return On Investment TTM | -293.05 |
| Revenue Growth3Y | -19.48 | Revenue Growth5Y | -10.81 |
| Revenue Growth Quarterly Yoy | 5,042.13 | Revenue Growth TTMYoy | 565.41 |
| Revenue Per Share TTM | 0.32 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 130 | 2 | 0 | 4 | 1 | 0 | 64.88M | $65.95M |
| Mar 31, 2025 | 125(-4%) | 24(+1100%) | 26(+%) | 33(+725%) | 33(+3200%) | 33(+%) | 56.56M(-13%) | $36.15M(-45%) |
| Jun 30, 2025 | 114(-9%) | 11(-54%) | 25(-4%) | 30(-9%) | 33 | 34(+3%) | 52.55M(-7%) | $26.84M(-26%) |